|
|
 |
 |
| |
 Printable version |
Biological assay for galactose-1 phosphate measurement application in subjects with galactosemia |
Annales de Biologie Clinique. Volume 70, Number 1, 85-8, Janvier-Février 2012, Biologie au quotidien
|
 Résumé
Texte intégral
|
Author(s) : Imene Braham, Bassem Charfeddine, Leila Ben Othmene, Souhir Neffati, Aida Mtar, Jihene Ben Abdallah, Med Ali Smach, Hedi Dridi, Khalifa Limem |
Summary : Congenital galactosemia is a hereditary, autosomal recessive and metabolic disease. It is linked to an enzyme deficiency, more commonly known by the deficiency of galactose-1- phosphate uridyltransferase (GALT), which is responsible for an accumulation of galactose-1- phosphate in the blood. Clinical symptoms appear early in infancy from the second week of life. They generally manifested by some disorders within liver, kidney, eye, gastrointestinal, neurological and also with cataracts. Currently, the clinical diagnosis remains difficult hence the importance of further investigations based on effective biological assessments to highlight the disease. The diagnosis of galactosemia is made by the laboratory test. The latter includes the determination of Gal-1-P which is done by a fluorometric method spot test. This study was conducted in order to assess the repeatability, reproducibility, accuracy, and effectiveness of the techniques used. We have found the CV for a repeatability (CV \= 5 %), reproducibility (CV \= 4 %) which confirms the accuracy of the method proceeded in this study. This method allows us to have a degree of inaccuracy less than 1%. According to the study of the effectiveness of “spot test”, we found that our technique is specific (Sp \= 93 %) and sensitive (Se \= 83 %). |
Keywords : congenital galactosemia, galactose-1-phosphate, fluorometric method « spot test » |
|
